InsideTracker vs Marek Health

Vial Take

Both platforms take metabolic health and longevity seriously, with lab depth at the core of each, so if you're optimizing biomarkers over time you'll find real substance on either side. The 7-point trust gap comes down to infrastructure: Marek Health discloses its pharmacy partners (Empower and Fagron), operates across 45 states with a licensed clinical team, and clears more third-party checkpoints, while InsideTracker's Harvard/MIT advisory board gives its science credibility but the platform leaves pharmacy and NPI details undocumented. If your goal is purely data-driven biomarker tracking without prescription care, InsideTracker's scientific rigor holds up; if you want a verifiable treatment pathway alongside the lab work, Marek Health gives you more to audit.

Biggest Differences

1. 1
   Pharmacy disclosure
   Marek Health publishes its compounding partners (Empower Pharmacy, Fagron), so you can verify the supply chain; InsideTracker does not name a pharmacy partner publicly.
2. 2
   Operating history
   InsideTracker has been operating since 2009 (17+ years of visible track record); Marek Health launched in 2019, giving you 10 fewer years of public record to evaluate.
3. 3
   Trust Score gap (7 points)
   Marek Health scores 80/100 to InsideTracker's 73/100, a 7-point spread driven by the differences below.